Results 201 to 210 of about 44,675 (226)

Thymic Hyperplasia-Associated Myasthenia Gravis in the Setting of Coexisting Graves' Disease. [PDF]

J ASEAN Fed Endocr Soc
Thewjitcharoen Y, Veerasomboonsin V, Himathongkam T.   +2 more
europepmc   +1 more source

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease.

J Clin Endocrinol Metab
Miyamura K, Ito M, Yamaoka H, Hisakado M, Nishihara E, Fukata S, Nishikawa M, Miyauchi A, Akamizu T.   +8 more
europepmc   +1 more source

Propylthiouracil-Induced Vasculitis in Relapsed Graves' Disease With Recent Iodine Exposure: A Therapeutic Dilemma. [PDF]

Cureus
Butt S, Majeed MS, Ali I, Sattar M, Jawed U.   +4 more
europepmc   +1 more source

Graves' Disease in the Elderly: A Case of Fluctuating Hyperthyroidism and Hypothyroidism Resulting in Challenging Management. [PDF]

Cureus
Fernando C, Soan C, Sankaran L, Parsad M.   +3 more
europepmc   +1 more source

Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".

J Clin Endocrinol Metab
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly